Structure-Activity Relationship in NOD2 Agonistic Muramyl Dipeptides

Nucleotide-binding oligomerization domain 2 (NOD2) is a receptor of the innate immune system that is capable of perceiving bacterial and viral infections. Muramyl dipeptide (MDP, N-acetyl muramyl ¬L-alanyl-D-isoglutamine), identified as the minimal immunologically active component of bacterial cell wall peptidoglycan (PGN), is recognized by NOD2. In terms of biological activities, MDP demonstrated vaccine adjuvant activity and stimulated non-specific protection against bacterial, viral, and parasitic infections and tumors. However, MDP has certain drawbacks including pyrogenicity, rapid elimination, andlack of oral bioavailability. Several detailed structure-activity relationship (SAR) studies around MDP scaffolds are being carried out to identify better NOD2 ligands. The present review elaborates a comprehensive SAR summarizing structural aspects of MDP derivatives in relation to NOD2 agonistic activity.